Literature DB >> 22718104

Comparison of verbal episodic memory measures: consortium to establish a registry for Alzheimer's disease--Neuropsychological Assessment Battery (CERAD-NAB) versus California Verbal Learning Test (CVLT).

Irene R Beck1, Alexa Gagneux-Zurbriggen, Manfred Berres, Kirsten I Taylor, Andreas U Monsch.   

Abstract

Episodic memory is affected early in the course of dementia. Two well-established tests to assess verbal episodic memory functioning are the Word List task from the Consortium to Establish a Registry for Alzheimer's disease Neuropsychological Assessment Battery (CERAD-NAB) and the California Verbal Learning Test (CVLT). In clinical and/or research settings, patients are typically administered either one or the other test, making statistical comparisons difficult. This study aimed to (i) compare the z-scores of these two tests in patients with MCI and different types of dementia and (ii) establish formulae to transform CERAD-NAB scores into CVLT scores and vice versa. Sixty-five patients completed both tests for the first time and within 10 days of each other. Pearson correlation coefficients indicated that the two tests assess similar aspects of episodic memory and that the CVLT is more sensitive to subtle episodic memory impairments. Finally, conversion formulae are provided and their implementation illustrated.

Entities:  

Mesh:

Year:  2012        PMID: 22718104     DOI: 10.1093/arclin/acs056

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  9 in total

1.  Neuropsychological tests for predicting cognitive decline in older adults.

Authors:  Kimberly M Baerresen; Karen J Miller; Eric R Hanson; Justin S Miller; Richelin V Dye; Richard E Hartman; David Vermeersch; Gary W Small
Journal:  Neurodegener Dis Manag       Date:  2015

2.  A new test to detect impairments of sequential visuospatial memory due to lesions of the temporal lobe.

Authors:  Thomas Eggert; Phuong Van Nguyen; Katharina Ernst; Sandra V Loosli; Andreas Straube
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

3.  Bone mineral density, adiposity, and cognitive functions.

Authors:  Hamid R Sohrabi; Kristyn A Bates; Michael Weinborn; Romola S Bucks; Stephanie R Rainey-Smith; Mark A Rodrigues; Sabine M Bird; Belinda M Brown; John Beilby; Matthew Howard; Arthur Criddle; Megan Wraith; Kevin Taddei; Georgia Martins; Athena Paton; Tejal Shah; Satvinder S Dhaliwal; Pankaj D Mehta; Jonathan K Foster; Ian J Martins; Nicola T Lautenschlager; Francis Mastaglia; Simon M Laws; Ralph N Martins
Journal:  Front Aging Neurosci       Date:  2015-02-18       Impact factor: 5.750

4.  A Longitudinal Item Response Theory Model to Characterize Cognition Over Time in Elderly Subjects.

Authors:  Marc Vandemeulebroecke; Björn Bornkamp; Tillmann Krahnke; Johanna Mielke; Andreas Monsch; Peter Quarg
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-08-29

Review 5.  Verbal memory measurement towards digital perspectives in first-episode psychosis: A review.

Authors:  Can Mişel Kilciksiz; Richard Keefe; James Benoit; Dost Öngür; John Torous
Journal:  Schizophr Res Cogn       Date:  2020-04-15

6.  Optimizing Cognitive Assessment Outcome Measures for Alzheimer's Disease by Matching Wordlist Memory Test Features to Scoring Methodology.

Authors:  Jason R Bock; Julie Russell; Junko Hara; Dennis Fortier
Journal:  Front Digit Health       Date:  2021-11-03

7.  Comparison of Traditional and Virtual Reality-Based Episodic Memory Performance in Clinical and Non-Clinical Cohorts.

Authors:  Michael D Barnett; Carmen J W Chek; Sydni S Shorter; Thomas D Parsons
Journal:  Brain Sci       Date:  2022-07-31

8.  The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.

Authors:  Panagiota Mistridis; Sabine Krumm; Andreas U Monsch; Manfred Berres; Kirsten I Taylor
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

9.  Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer's disease.

Authors:  Emilie T Reas; Donald J Hagler; Nathan S White; Joshua M Kuperman; Hauke Bartsch; Karalani Cross; Richard Q Loi; Akshara R Balachandra; M J Meloy; Christina E Wierenga; Douglas Galasko; James B Brewer; Anders M Dale; Linda K McEvoy
Journal:  Alzheimers Res Ther       Date:  2017-08-02       Impact factor: 6.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.